Sasol Ltd: Form 20-F/A for the period ended Jun 30, 2018
Filed with the SEC on Sep 21, 2018 and accepted by EDGAR at Sep 21, 2018, 12:25 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2017-07-01 to 2018-06-30 | ZAR 181.46bn | ifrs-full:Revenue |
| Operating income | 12 months2017-07-01 to 2018-06-30 | ZAR 17.75bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2017-07-01 to 2018-06-30 | ZAR 5.56bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2017-07-01 to 2018-06-30 | ZAR 8.73bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months2017-07-01 to 2018-06-30 | ZAR 14.18 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2017-07-01 to 2018-06-30 | ZAR 14.26 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2017-07-01 to 2018-06-30 | ZAR 26.35bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2017-07-01 to 2018-06-30 | ZAR 714.0m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2018-06-30 | ZAR 17.13bn | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2018-06-30 | ZAR 81.26bn | ifrs-full:CurrentAssets |
| Total assets | At period end2018-06-30 | ZAR 439.24bn | ifrs-full:Assets |
| Current liabilities | At period end2018-06-30 | ZAR 59.96bn | ifrs-full:CurrentLiabilities |
| Shareholders' equity | At period end2018-06-30 | ZAR 222.99bn | ifrs-full:EquityAttributableToOwnersOfParent |
Source: SEC EDGAR, the filing index for accession 0001104659-18-057921. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.